Delayed Administration of Risedronate Does Not Restore Bone Loss In Patients Following Total Hip Arthroplasty - A randomized, double blinded clinical study

Delayed Administration of Risedronate Does Not Restore Bone Loss In Patients Following Total Hip Arthroplasty - A randomized, double blinded clinical study

Background: Periprosthetic bone loss after total hip arthroplasty (THA) increases the risk of serious post-operative complications. Previous studies have reported the beneficial effect of risedronate therapy to improve periprosthetic bone mineral density (BMD) around new implants. The current study...

Full description

Bibliographic Details
Main Authors: David Lionberger, MD, Joshua Liao, Mitchell Eggers, PhD, Sahar Bawkher, BS
Format: Article
Language:English
Published: Joint Implant Surgery & Research Foundation 2013-10-01
Series:Reconstructive Review
Online Access:https://reconstructivereview.org/ojs/index.php/rr/article/view/32

Similar Items

Similar Items